Transposons, DNA sequences that can self-replicate and move (jump) throughout the genome, are widespread and can affect cell ...

While scientists have known for more than two decades that all cells use a strategy called RNA interference to regulate gene ...

Arrowhead Pharmaceuticals (NASDAQ:ARWR) is moving into a more commercial phase while continuing to expand its RNA interference pipeline, Chief Executive Officer Chris Anzalone said during a ...

Benitec Biopharma Inc. company and executive profile by Barron's. View the latest BNTC company infomation and executive bios.

Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced a ...